CRL+73.43%14.3%
HAPN+30.27%14.3%
IQ-30.65%14.3%
LONN.SW+2.46%14.3%
MEDP+36.57%14.3%
TMO+28.71%14.3%
WAT+44.03%14.3%
As of Aug 6, 2026, 4:25 AM ET
Regulatory Testing '26: Life Sciences & Lab Tests Constituents
Charles River Laboratories International, Inc.CRL | 14.3% | 11.36% | 15.07% | 12.66% | 12.13% | 30.70% | 46.07% | 74.65% | 73.43% | $12.56B |
iQIYI, Inc.IQ | 14.3% | -3.01% | 5.74% | 20.56% | 1.57% | -32.81% | -19.37% | -41.10% | -30.65% | $1.24B |
LendingClub CorporationHAPN | 14.3% | 0.00% | 13.18% | 3.60% | 6.79% | 7.92% | 37.09% | 90.49% | 30.27% | $2.36B |
Lonza Group AGLONN.SW | 14.3% | 0.90% | 3.27% | -3.88% | -0.47% | 2.15% | -0.65% | 14.81% | 2.46% | $48.58B |
Medpace Holdings, Inc.MEDP | 14.3% | 2.20% | -2.27% | 4.01% | 1.84% | 4.65% | 30.10% | 88.85% | 36.57% | $16.41B |
Thermo Fisher Scientific Inc.TMO | 14.3% | 2.32% | 1.68% | 11.64% | 0.61% | -0.28% | 10.88% | 18.15% | 28.71% | $214.73B |
Waters CorporationWAT | 14.3% | 0.99% | 6.76% | 5.57% | 6.01% | 5.31% | 25.24% | 10.30% | 44.03% | $26.07B |
| Theme return | — | 2.11% | 6.20% | 8.29% | 3.13% | 3.61% | 18.12% | 37.91% | 23.97% | — |
| Average | 14.3% | 2.11% | 6.20% | 7.74% | 4.07% | 2.52% | 18.48% | 36.59% | 26.40% | $45.99B |
| Median | 14.3% | 0.99% | 5.74% | 5.57% | 1.84% | 4.65% | 25.24% | 18.15% | 30.27% | $16.41B |
| Std Dev | 0.0% | 4.12% | 5.72% | 7.31% | 4.14% | 17.29% | 21.20% | 45.71% | 30.41% | $70.49B |
| Min | 14.3% | -3.01% | -2.27% | -3.88% | -0.47% | -32.81% | -19.37% | -41.10% | -30.65% | $1.24B |
| Max | 14.3% | 11.36% | 15.07% | 20.56% | 12.13% | 30.70% | 46.07% | 90.49% | 73.43% | $214.73B |
| % Positive Tickers | 71.43% | 85.71% | 85.71% | 85.71% | 71.43% | 71.43% | 85.71% | 85.71% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Regulatory Testing '26: Life Sciences & Lab Tests tracks 7 publicly listed stocks in this theme: CRL, HAPN, IQ, LONN.SW, MEDP, TMO, WAT. See the constituent table for details.